tldrdailynews.com logo

Pfizer Acquires Metsera to Strengthen Obesity Treatment Portfolio

1 min read
Source: Yahoo Finance
Pfizer Acquires Metsera to Strengthen Obesity Treatment Portfolio
Photo: Yahoo Finance
TL;DR Summary

Pfizer has acquired biotech company Metsera for $4.9 billion to enhance its portfolio of long-lasting GLP-1 receptor agonists for weight loss, aiming to compete in the growing obesity treatment market, with the deal including milestone-based payments and a focus on monthly dosing therapies.

Topics:top-news#acquisition#business#glp-1ra#metsera#pfizer#weight-loss
Share this article
  1. Pfizer buys monthly GLP-1RA developer Metsera for $4.9bn  Yahoo Finance
  2. Pfizer amps up push into obesity treatments with $4.9B deal for Metsera  ABC News - Breaking News, Latest News and Videos
  3. Pfizer to Buy Weight-Loss Drug Developer Metsera for Up to $7.3 Billion  The Wall Street Journal
  4. Metsera Stock Jumps 60%. Pfizer Is Jumping Back Into the Weight-Loss Race.  Barron's
  5. Pfizer to Acquire Metsera and its Next-Generation Obesity Portfolio  Business Wire

Reading Insights

Total Reads

1

Unique Readers

13

Time Saved

2 min

vs 3 min read

Condensed

91%

461 → 43 words

Want the full story? Read the original article

Read on Yahoo Finance